Christian Roux talks us through the findings of the ADEM trial, which demonstrated similar pain outcomes among patients with hand osteoarthritis treated with methotrexate versus placebo (7:05).
13-11-2019 | Osteoarthritis | Video | Article
Browse topics
In focus
Bimekizumab: Dual IL-17A/IL-17F inhibition in SpA
Anifrolumab for the treatment of SLE
JAK inhibitor safety: Weighing up the data and understanding the risks
Rituximab and rheumatology practice in the COVID-19 era
Safety snapshot: Upadacitinib in patients with PsA
Repurposing rheumatology drugs for COVID-19
Telemedicine in rheumatology: COVID-19 and beyond
Managing PsA in resource-limited settings
Conferences